

Many life sciences companies are preparing for the shift from Veeva CRM to Vault CRM as if it were a routine system upgrade. It isn't.

Life sciences organizations face a critical juncture in how they manage customer relationships, commercial operations, and technology infrastructure. CRM decisions that once seemed purely technical have evolved into strategic imperatives, directly tied to broader objectives around business agility, data connectivity, and omnichannel execution.

Implementing effective digital asset management in the pharmaceutical industry requires following established best practices to ensure regulatory compliance and operational efficiency. As organizations navigate the complexities of what is digital asset management in a highly regulated environment, a strategic approach has become essential for success.

Sales representatives in the life sciences industry should focus on efficiently relaying information about their products to healthcare professionals (HCPs). However, they often encounter challenges while using their Veeva CRM system.